Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

RSA appoints John Callagher as CEO

He takes over from Nick Stephens who becomes executive chairman

FDA launches safety probe into Boehringer’s Mirapex

Regulator concerned about potential heart risk link to Parkinson's disease drug

- PMLiVE

Roche plans translational research centre in New York

Follows plan to close New Jersey headquarters

- PMLiVE

This month in 1901: Birth of Charles Brenton Huggins

This month in pharma: September 1901, the birth of the man who linked hormones with cancer

- PMLiVE

Sanofi signs tuberculosis research deal with TB Alliance

Aims to shorten regimens and tackle drug-resistant forms of infection

- PMLiVE

Indian online doctor community supported by new patient portal

Medigrity Innovations' eMedWorld information site 'tightly integrated' with its physician community DocLynk

Lundbeck files novel antidepressant vortioxetine in EU

Could counter loss of patent for big-selling Lexapro/Cipralex

- PMLiVE

Boehringer cancer R&D programme bears first fruit

Submits afatinib in Europe to treat lung cancer

- PMLiVE

Bayer fails to block Indian Nexavar compulsory licence

Loses ‘stay’ appeal against Natco Pharma in Chennai court

Silence Therapeutics appoints Michael Khan as chief medical adviser

Will advise on translational research for its siRNA-based therapeutics

- PMLiVE

GSK’s Peter Harding appointed president of PAGB

Takes over from J&J’s Alex Pitt to lead UK consumer healthcare trade body

Revolution or evolution: is it the end of SMR and ASMR in France?

As Marisol Touraine aims to cut healthcare spending and patients and doctors push for innovative drugs to be priced against the standard of care, what lies in store for pharma?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links